Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Advertise
  • SUBSCRIBE

Cytokinetics, Astellas Pharma to Collaborate

By Pharmaceutical Processing | June 25, 2013

Drug developer Cytokinetics and Astellas Pharma Inc. are teaming up on the research, development and commercialization of skeletal muscle activators.

The companies said Tuesday that the main goal is to advance some therapies for diseases and medical conditions related to muscle weakness.

Japan’s Astellas will have exclusive rights to develop and commercialize drug candidates that may come about from these activities, subject to certain Cytokinetics’ development and commercialization rights. Astellas also has an exclusive license from South San Francisco, Calif.-based Cytokinetics Inc. for the rights to co-develop and commercialize one of its drug candidates, CK-2127107 in certain indications. The drug candidate is currently in early-stage testing.

The companies expect to collaborate over two years, and Cytokinetics is eligible to receive about $40 million as an upfront payment and reimbursement of research and development during that time. In addition, Cytokinetics is eligible to receive more than $450 million in pre-commercialization and commercialization milestones plus royalties.

Cytokinetics’ stock fell 40 cents, or 3.2 percent, to $11.90 in afternoon trading. The stock has more than doubled in the year to date.

Related Articles Read More >

This is a photo of the Fujifilm Diosynth Biotechnologies plant under construction in Holly Springs, North Carolina.
Fujifilm, Regeneron ink $3B U.S. manufacturing agreement
This is the logo of Johnson & Johnson.
J&J breaks ground on $2B manufacturing facility in North Carolina
sherwin-williams-pharma-facility (1)
Sherwin-Williams expands flooring solutions for pharma facilities
PHARMAP 2025: Pharma leaders converge in Berlin for fifth anniversary summit
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Advertise
  • SUBSCRIBE